Publications by authors named "Ross England"

Claim this Profile
S
Should birth-dose vaccines for preterm newborns still be debated?
Tinsae Alemayehu, Ross N England, Benson Oguttu, Daniel Jarovsky

Int J Infect Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model.
Ross N England, Elizabeth M Drapeau, Mohamad-Gabriel Alameh, Reihaneh Hosseinzadeh, Drew Weissman

NPJ Vaccines· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-Limited COVID-19 in a Patient with Artemis Hypomorphic SCID.
Stanislaw J Gabryszewski, Ross N England, Di Sun, Tatiana Londoño Gentile, William Hochgertel

J Clin Immunol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulomatous Dermatitis Associated With Rubella Virus Infection in an Adult With Immunodeficiency.
Bridget E Shields, Ludmila Perelygina, Sara Samimi, Paul Haun, Thomas Leung, Ross England

JAMA Dermatol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Blood Plasma Shapes Distinct Neonatal TLR-Mediated Dendritic Cell Activation via Expression of the MicroRNA Let-7g.
Ross England, Jensen Pak, Mark Liu, Shun Rao, Al Ozonoff

Immunohorizons· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pearls & Oy-sters: Bilateral globus pallidus lesions in a patient with COVID-19.
Catherine V Kulick-Soper, Jillian L McKee, Ronald L Wolf, Suyash Mohan, Joel M Stein, Ross N England

Neurology· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical Center.
Lauren A Eberly, Aaron Richterman, Anne G Beckett, Bram Wispelwey, Regan H Marsh, Ross England

Circ Heart Fail· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of MiR133a expression by IL-19 targets LDLRAP1 and reduces oxLDL uptake in VSMC.
Khatuna Gabunia, Allison B Herman, Mitali Ray, Sheri E Kelemen, Ross N England

J Mol Cell Cardiol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-19 induces angiogenesis in the absence of hypoxia by direct and indirect immune mechanisms.
Farah Kako, Khatuna Gabunia, Mitali Ray, Sheri E Kelemen, Ross N England

Am J Physiol Cell Physiol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-19 reduces ligation-mediated neointimal hyperplasia by reducing vascular smooth muscle cell activation.
Stephen Ellison, Khatuna Gabunia, James M Richards, Sheri E Kelemen, Ross N England

Am J Pathol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attenuation of experimental atherosclerosis by interleukin-19.
Stephen Ellison, Khatuna Gabunia, Sheri E Kelemen, Ross N England, Rosario Scalia

Arterioscler Thromb Vasc Biol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-19 decreases leukocyte-endothelial cell interactions by reduction in endothelial cell adhesion molecule mRNA stability.
Ross N England, Kyle J Preston, Rosario Scalia, Michael V Autieri

Am J Physiol Cell Physiol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-inflammatory effects of interleukin-19 in vascular disease.
Ross N England, Michael V Autieri

Int J Inflam· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased atherosclerosis and vascular smooth muscle cell activation in AIF-1 transgenic mice fed a high-fat diet.
Laura J Sommerville, Sheri E Kelemen, Stephen P Ellison, Ross N England, Michael V Autieri

Atherosclerosis· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-inflammatory cytokine interleukin-19 inhibits smooth muscle cell migration and activation of cytoskeletal regulators of VSMC motility.
Khatuna Gabunia, Surbhi Jain, Ross N England, Michael V Autieri

Am J Physiol Cell Physiol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis